Emboli, Thrombus Extraction Catheter Cleared by FDA


January 13, 2011

January 13, 2011 – A catheter that removes emboli and thrombi from vessels in the coronary and peripheral vasculature has received 510(k) clearance from the U.S. Food and Drug Administration. The Xpress-Way RX manual extraction catheter is manufactured by Kaneka Corp. and distributed by Atrium Medical in the United States.

The catheter is an ultra-low profile manual aspiration system designed for the removal of fresh, soft emboli and thrombi in both coronary and peripheral vessels. It incorporates a removable stylet and has been designed with enhanced pushability, anti-kinking, trackability and crossability. Outside the United States, it is marketed as the Thrombuster II.

Thrombus aspiration uses the suction force generated from a syringe to pull soft, fresh thrombus from a vessel. Thrombus can form throughout the body, but manual thrombus aspiration is commonly used in patients who have heart attacks. The main cause of heart attacks is due to a plaque rupture in one of the major coronary arteries, which causes a blood clot to form, reducing blood flow and depriving the heart muscle downstream of oxygen-rich blood. Manual thrombus aspiration is one tool used by interventional cardiologists to remove the blood clot and restore critical blood flow to the heart muscle.

For more information: www.kaneka.co.jp, www.atriummed.com

The content of this field is kept private and will not be shown publicly.
Type the characters you see in this picture. (verify using audio)
Type the characters you see in the picture above; if you can't read them, submit the form and a new image will be generated. Not case sensitive.